Instapath, a biomedical startup founded by engineers and scientists from Tulane University, is transforming cancer diagnosis with its innovative optical scanning microscopy technology. The company’s mission is to drastically reduce the time it takes to deliver pathology results, enabling patients to receive a diagnosis within minutes rather than days.